|
SENP3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.757100001753E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.79810000000558E-07 |
| Normal-vs-Stage2 |
3.065500E-02 |
| Normal-vs-Stage3 |
1.90540000000183E-06 |
| Normal-vs-Stage4 |
1.00110000000875E-06 |
| Stage1-vs-Stage2 |
2.433400E-01 |
| Stage1-vs-Stage3 |
6.244600E-01 |
| Stage1-vs-Stage4 |
3.729400E-01 |
| Stage2-vs-Stage3 |
1.720200E-01 |
| Stage2-vs-Stage4 |
1.019630E-01 |
| Stage3-vs-Stage4 |
6.300000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.13880000008582E-07 |
| Normal-vs-AfricanAmerican |
2.967700E-02 |
| Normal-vs-Asian |
6.785200E-04 |
| Caucasian-vs-AfricanAmerican |
1.843790E-01 |
| Caucasian-vs-Asian |
8.961800E-01 |
| AfricanAmerican-vs-Asian |
2.489600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.04499999986629E-07 |
| Normal-vs-Female |
3.20780000007126E-07 |
| Male-vs-Female |
2.613600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.74509999995021E-06 |
| Normal-vs-Age(41-60Yrs) |
1.7405999996889E-07 |
| Normal-vs-Age(61-80Yrs) |
1.594190E-04 |
| Normal-vs-Age(81-100Yrs) |
1.037760E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.084600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.376600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.522400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.465600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.526000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.529800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.437700E-02 |
| Classical-VS-Follicular |
2.797600E-01 |
| Classical-VS-Other |
3.332600E-01 |
| Classical-VS-Normal |
2.22699999996578E-06 |
| Tall-VS-Follicular |
6.273400E-01 |
| Tall-VS-Other |
9.181200E-01 |
| Tall-VS-Normal |
7.84610000303942E-08 |
| Follicular-VS-Other |
7.990000E-01 |
| Follicular-VS-Normal |
6.2598999999941E-05 |
| Other-VS-Normal |
7.579700E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.43509999994684E-06 |
| Normal-vs-N1 |
6.15749999988147E-07 |
| N0-vs-N1 |
8.816200E-02 |
|
|
